August 12, 2026 New AI Sales Agent BloomCONNECT Promises to Turn Every Missed DM Into a Booked Appointment
August 12, 2026 Akeso Advances IO2.0 + ADC2.0 Strategy: First Patient Dosed in Phase II Study of TROP2/Nectin-4 Bispecific ADC (AK146D1) Combined with Ivonescimab in Breast Cancer
August 12, 2026 HanchorBio and Taiwan Cancer Moonshot Project-NTU Subteam Led by Professor Sung-Liang Yu Establish Strategic Collaboration to Advance Precision Oncology
August 12, 2026 Virtuix Reschedules First Quarter Fiscal 2027 Results Following Recent Transition to New Independent Accounting Firm